CXCL1 and chronic obstructive pulmonary disease: In our study, we demonstrated for the first time that GRO-α, a CXC chemokine with strong activating and chemotactic abilities for neutrophils, was found to be raised in the EBC from exacerbated, but not stable, COPD patients.